keyword
https://read.qxmd.com/read/37627183/understanding-dna-damage-response-and-dna-repair-in-multiple-myeloma
#21
REVIEW
Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael, Francesca Cottini
Multiple myeloma (MM) is a plasma cell malignancy characterized by several genetic abnormalities, including chromosomal translocations, genomic deletions and gains, and point mutations. DNA damage response (DDR) and DNA repair mechanisms are altered in MM to allow for tumor development, progression, and resistance to therapies. Damaged DNA rarely induces an apoptotic response, given the presence of ataxia-telangiectasia mutated ( ATM ) loss-of-function or mutations, as well as deletions, mutations, or downregulation of tumor protein p53 (TP53) and tumor protein p73 (TP73)...
August 17, 2023: Cancers
https://read.qxmd.com/read/37622400/p53-amyloid-pathology-is-correlated-with-cancer-grades-irrespective-of-the-mutant-or-wildtype-forms
#22
JOURNAL ARTICLE
Shinjinee Sengupta, Namrata Singh, Ajoy Paul, Debalina Datta, Debdeep Chatterjee, Semanti Mukherjee, Laxmikant Gadhe, Jyoti Devi, Yeshwant M, Mohit Kumar Jolly, Samir K Maji
p53 mutation and amyloid formation are long associated with cancer pathogenesis, however, the direct demonstration of the link between p53 amyloid load and cancer progression is lacking. Using multi-disciplinary techniques and a cohort of 59 tumor tissues (53 from Indian cancer patients and six normal tissues) of oral and stomach cancer types, we showed that p53 amyloid load and cancer grades are highly correlated. Further, next-generation sequencing (NGS) data suggest that not only mutant p53 (e.g., SNVs, deletions, and insertions) but wild-type p53 also formed amyloids either in the nucleus (50%) and/or in the cytoplasm in most cancer tissues...
August 25, 2023: Journal of Cell Science
https://read.qxmd.com/read/37568607/tap73-inhibits-emt-and-cell-migration-in-pancreatic-cancer-cells-through-promoting-smad4-expression-and-smad4-dependent-inhibition-of-erk-activation
#23
JOURNAL ARTICLE
Hendrik Ungefroren, Björn Konukiewitz, Rüdiger Braun, Ulrich Friedrich Wellner, Hendrik Lehnert, Jens-Uwe Marquardt
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease due to early metastatic spread, late diagnosis and the lack of efficient therapies. A major driver of cancer progression and hurdle to successful treatment is transforming growth factor (TGF)-β. Recent data from pancreatic cancer mouse models showed that transcriptionally active p73 (TAp73), a p53 family member, inhibits tumor progression through promoting tumor suppressive canonical TGF-β/Smad signaling, while preventing non-canonical TGF-β signaling through extracellular signal-regulated kinases (ERK)1/2...
July 26, 2023: Cancers
https://read.qxmd.com/read/37563629/the-hippo-signaling-pathway-contributes-to-the-2-5-hexadion-induced-apoptosis-of-ovarian-granulosa-cells
#24
JOURNAL ARTICLE
Yi Sun, Huiting Chen, Sichuan Chen, Xueming Xu, Wenchang Zhang, Yuchen Li
Although n-hexane can induce ovarian damage by inducing ovarian granulosa cell (GC) apoptosis, the mechanism underlying this induction of apoptosis has not been fully elucidated. In this study, rat ovarian GCs were exposed to different concentrations of 2,5-hexanedione (2,5-HD) (the main metabolite of n-hexane) in vitro to observe apoptosis, and the mechanism was further explored via mRNA microarray analysis. Hoechst 33258 staining and flow cytometry suggested that the apoptosis rate of ovarian GC apoptosis was significantly increased in the 2,5-HD-treated group...
August 11, 2023: Journal of Ovarian Research
https://read.qxmd.com/read/37559979/indisulam-exerts-anticancer-effects-via-modulation-of-transcription-translation-and-alternative-splicing-on-human-cervical-cancer-cells
#25
JOURNAL ARTICLE
Zhihui Dou, Xuetian Zhang, Wei Su, Taotao Zhang, Fei Ye, Dapeng Zhao, Xiaohua Chen, Qiang Li, Hong Zhang, Cuixia Di
Indisulam is a synthetic sulfonamides drug with anticancer activity in various tumors. However, the effect and molecular mechanism of indisulam have still not been studied in human cervical cancer. We treated human cervical cancer cell lines (HeLa and C33A) with indisulam, evaluated its efficacy, and investigated its molecular targets. Indisulam inhibited tumor growth and induced RBM39 degradation in a dose-dependent manner. RNA-seq and proteomics analysis revealed that indisulam disrupted transcriptional regulation pathways related to mRNA splicing and apoptosis...
2023: American Journal of Cancer Research
https://read.qxmd.com/read/37555250/imatinib-prevents-dexamethasone-induced-pancreatic-%C3%AE-cell-apoptosis-via-decreased-trail-and-dr5
#26
JOURNAL ARTICLE
Suchanoot Kutpruek, Kanchana Suksri, Petcharee Maneethorn, Namoiy Semprasert, Pa-Thai Yenchitsomanus, Suwattanee Kooptiwut
Prolonged administration of dexamethasone, a potent anti-inflammatory drug, can lead to steroid-induced diabetes. Imatinib, a medication commonly prescribed for chronic myeloid leukemia (CML), has been shown to improve diabetes in CML patients. Our recent study demonstrated that dexamethasone induces pancreatic β-cell apoptosis by upregulating the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor, death receptor 5 (DR5). We hypothesized that imatinib may protect against dexamethasone-induced pancreatic β-cell apoptosis by reducing the expression of TRAIL and DR5, thereby favorably modulating downstream effectors in apoptotic pathways...
August 9, 2023: Journal of Cellular Biochemistry
https://read.qxmd.com/read/37386079/mek1-2-regulate-normal-bcr-and-abl1-tumor-suppressor-functions-to-dictate-ato-response-in-tki-resistant-ph-leukemia
#27
JOURNAL ARTICLE
Laura Mazzera, Manuela Abeltino, Guerino Lombardi, Anna Maria Cantoni, Stefano Jottini, Attilio Corradi, Micaela Ricca, Elena Rossetti, Federico Armando, Angelo Peli, Anna Ferrari, Giovanni Martinelli, Maria Teresa Scupoli, Carlo Visco, Massimiliano Bonifacio, Alessia Ripamonti, Carlo Gambacorti-Passerini, Antonio Bonati, Roberto Perris, Paolo Lunghi
Resistance to tyrosine kinase inhibitors (TKIs) remains a clinical challenge in Ph-positive variants of chronic myeloid leukemia. We provide mechanistic insights into a previously undisclosed MEK1/2/BCR::ABL1/BCR/ABL1-driven signaling loop that may determine the efficacy of arsenic trioxide (ATO) in TKI-resistant leukemic patients. We find that activated MEK1/2 assemble into a pentameric complex with BCR::ABL1, BCR and ABL1 to induce phosphorylation of BCR and BCR::ABL1 at Tyr360 and Tyr177, and ABL1, at Thr735 and Tyr412 residues thus provoking loss of BCR's tumor-suppression functions, enhanced oncogenic activity of BCR::ABL1, cytoplasmic retention of ABL1 and consequently drug resistance...
June 29, 2023: Leukemia
https://read.qxmd.com/read/37364764/plagl2-induces-nucleus-pulposus-cell-apoptosis-via-regulating-rassf5-expression-and-thus-accelerates-intervertebral-disc-degeneration
#28
JOURNAL ARTICLE
GuangDuo Zhu, XiaoWei Yang, WeiWei Zhou, Xu Lian, YingJie Hao
Excessive apoptosis of nucleus pulposus (NP) cells is the main pathological change in intervertebral disc degeneration (IVDD) progression. Pleomorphic adenoma gene like-2 (PLAGL2) plays a key role in cell apoptosis, however, the effect of PLAGL2 on IVDD has not been clarified yet. In this study, we established mouse IVDD models via the annulus fibrosis needle puncture, TUNEL and safranin O staining were used to verify the successful establishment of IVDD models, and PLAGL2 expression was detected in disc tissues...
June 24, 2023: Experimental Cell Research
https://read.qxmd.com/read/37345171/metal-based-anticancer-complexes-and-p53-how-much-do-we-know
#29
REVIEW
Samah Mutasim Alfadul, Egor M Matnurov, Alexander E Varakutin, Maria V Babak
P53 plays a key role in protecting the human genome from DNA-related mutations; however, it is one of the most frequently mutated genes in cancer. The P53 family members p63 and p73 were also shown to play important roles in cancer development and progression. Currently, there are various organic molecules from different structural classes of compounds that could reactivate the function of wild-type p53, degrade or inhibit mutant p53, etc. It was shown that: (1) the function of the wild-type p53 protein was dependent on the presence of Zn atoms, and (2) Zn supplementation restored the altered conformation of the mutant p53 protein...
May 19, 2023: Cancers
https://read.qxmd.com/read/37271639/selinexor-in-patients-with-advanced-and-recurrent-endometrial-cancer
#30
REVIEW
Giorgio Bogani, Bradley J Monk, Robert L Coleman, Ignace Vergote, Ana Oakin, Isabelle Ray-Coquard, Andrea Mariani, Giovanni Scambia, Francesco Raspagliesi, Bruno Bolognese
Selinexor is an oral inhibitor of the nuclear export protein called Exportin 1 (XPO1) with demonstrated antitumor activity in hematological and solid tumors. Selinexor, blocking XPO1, induces nuclear localization of tumor suppressor proteins (including p53, p73, BRCA1, and pRB), leading to the selective induction of apoptosis, and inhibition of DNA damage repair proteins. XPO1 overexpression is common in endometrial cancers. Phase I and II trials reported the antitumor activity of selinexor in patients with endometrial carcinoma...
May 30, 2023: Current Problems in Cancer
https://read.qxmd.com/read/37207995/pulsed-electromagnetic-fields-combined-with-adipose-derived-stem-cells-protect-ischemic-myocardium-by-regulating-mir-20a-5p-e2f1-p73-signalling
#31
JOURNAL ARTICLE
Yang Wang, Li Chen, Lu Wang, Gaiqin Pei, Hongxin Cheng, Qing Zhang, Shiqi Wang, Danrong Hu, Yong He, Chengqi He, Chenying Fu, Quan Wei
Myocardial infarction (MI) is a serious threat to human health. Although monotherapy with pulsed electromagnetic fields (PEMFs) or adipose-derived stem cells (ADSCs) has been reported to have positive effect on the treatment of MI, a satisfactory outcome has not yet been achieved. In recent years, combination therapy has attracted widespread interest. Herein, we explored the synergistic therapeutic effect of combination therapy with PEMFs and ADSCs on MI and found that the combination of PEMFs and ADSCs effectively reduced infarct size, inhibited cardiomyocyte apoptosis and protected the cardiac function in mice with MI...
May 19, 2023: Stem Cells
https://read.qxmd.com/read/37182132/the-dual-role-of-p63-in-cancer
#32
REVIEW
Yongfeng Xu, Xiaojuan Yang, Qunli Xiong, Junhong Han, Qing Zhu
The p53 family is made up of three transcription factors: p53, p63, and p73. These proteins are well-known regulators of cell function and play a crucial role in controlling various processes related to cancer progression, including cell division, proliferation, genomic stability, cell cycle arrest, senescence, and apoptosis. In response to extra- or intracellular stress or oncogenic stimulation, all members of the p53 family are mutated in structure or altered in expression levels to affect the signaling network, coordinating many other pivotal cellular processes...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37131797/p73-activates-transcriptional-signatures-of-basal-lineage-identity-and-ciliogenesis-in-pancreatic-ductal-adenocarcinoma
#33
Stella K Hur, Tim D D Somerville, Xiaoli S Wu, Diogo Maia-Silva, Osama E Demerdash, David A Tuveson, Faiyaz Notta, Christopher R Vakoc
During the progression of pancreatic ductal adenocarcinoma (PDAC), tumor cells are known to acquire transcriptional and morphological properties of the basal (also known as squamous) epithelial lineage, which leads to more aggressive disease characteristics. Here, we show that a subset of basal-like PDAC tumors aberrantly express p73 (TA isoform), which is a known transcriptional activator of basal lineage identity, ciliogenesis, and tumor suppression in normal tissue development. Using gain- and loss- of function experiments, we show that p73 is necessary and sufficient to activate genes related to basal identity (e...
April 21, 2023: bioRxiv
https://read.qxmd.com/read/37098971/identification-and-functional-comparison-of-novel-alternatively-spliced-isoforms-of-human-yap
#34
JOURNAL ARTICLE
Lianlian Liu, Junlei Zhang, Jiaqi Wang, Yanping Tian, Jiali Wang, Yixiao Xu, Yuda Cheng, Meng Yu, Jiangjun Wang, Yi Yang, Xueyue Wang, Ran Yang, Wei Wu, Chen Zhang, Yan Hu, Rui Jian, Lan Xiao, Yan Ruan
As a key effector of the Hippo pathway, Yes-associated protein (YAP) is a major regulator of cell proliferation and apoptosis. In this study, 23 hYAP isoforms were identified in HEK293 cells, with 14 isoforms being reported for the first time. These isoforms were classified into hYAP-a and hYAP-b isoforms based on the variation in exon 1. The two groups of isoforms showed distinctly different subcellular localizations. hYAP-a isoforms could activate TEAD- or P73-mediated transcription, affect the proliferation rate and enhance the cellular chemosensitivity of HEK293 cells...
April 26, 2023: FEBS Open Bio
https://read.qxmd.com/read/37046726/identifying-key-regulators-of-keratinization-in-lung-squamous-cell-cancer-using-integrated-tcga-analysis
#35
JOURNAL ARTICLE
Yusri Dwi Heryanto, Seiya Imoto
Keratinization is one of lung squamous cell cancer's (LUSC) hallmark histopathology features. Epithelial cells produce keratin to protect their integrity from external harmful substances. In addition to their roles as cell protectors, recent studies have shown that keratins have important roles in regulating either normal cell or tumor cell functions. The objective of this study is to identify the genes and microRNAs (miRNAs) that act as key regulators of the keratinization process in LUSC. To address this goal, we classified LUSC samples from GDC-TCGA databases based on their keratinization molecular signatures...
March 30, 2023: Cancers
https://read.qxmd.com/read/36979713/nek1-mediated-phosphorylation-of-yap1-is-key-to-prostate-cancer-progression
#36
JOURNAL ARTICLE
Ishita Ghosh, Md Imtiaz Khalil, Rusella Mirza, Judy King, Damilola Olatunde, Arrigo De Benedetti
The key to preventing mCRPC progression is understanding how androgen-dependent PCa cells progress to independence and modify their transcriptional repertoire accordingly. We recently identified a novel axis of the Hippo pathway characterized by the sequential kinase cascade induced by androgen deprivation, AR- >TLK1B>NEK1>pYAP1-Y407, leading to CRPC adaptation. Phosphorylation of YAP1-Y407 increases upon ADT or induction of DNA damage, correlated with the known increase in NEK1 expression/activity, and this is suppressed in the Y407F mutant...
February 28, 2023: Biomedicines
https://read.qxmd.com/read/36972210/retraction-p63-and-p73-transcriptionally-regulate-genes-involved-in-dna-repair
#37
(no author information available yet)
No abstract text is available yet for this article.
March 2023: PLoS Genetics
https://read.qxmd.com/read/36883841/the-e2f4-p130-repressor-complex-cooperates-with-oncogenic-%C3%AE-np73%C3%AE-to-inhibit-gene-expression-in-human-papillomavirus-38-e6-e7-transformed-keratinocytes-and-in-cancer-cells
#38
JOURNAL ARTICLE
Valerio Taverniti, Hanna Krynska, Assunta Venuti, Marie-Laure Straub, Cécilia Sirand, Eugenie Lohmann, Maria Carmen Romero-Medina, Stefano Moro, Alexis Robitaille, Luc Negroni, Denise Martinez-Zapien, Murielle Masson, Massimo Tommasino, Katia Zanier
Tumor suppressor p53 and its related proteins, p63 and p73, can be synthesized as multiple isoforms lacking part of the N- or C-terminal regions. Specifically, high expression of the ΔNp73α isoform is notoriously associated with various human malignancies characterized by poor prognosis. This isoform is also accumulated by oncogenic viruses, such as Epstein-Barr virus (EBV), as well as genus beta human papillomaviruses (HPV) that appear to be involved in carcinogenesis. To gain additional insight into ΔNp73α mechanisms, we have performed proteomics analyses using human keratinocytes transformed by the E6 and E7 proteins of the beta-HPV type 38 virus as an experimental model (38HK)...
March 8, 2023: MSphere
https://read.qxmd.com/read/36848235/protein-adduction-causes-non-mutational-inhibition-of-p53-tumor-suppressor
#39
JOURNAL ARTICLE
Ravindran Caspa Gokulan, Kodisundaram Paulrasu, Jamal Azfar, Wael El-Rifai, Jianwen Que, Olivier G Boutaud, Yuguang Ban, Zhen Gao, Monica Garcia Buitrago, Sergey I Dikalov, Alexander I Zaika
p53 is a key tumor suppressor that is frequently mutated in human tumors. In this study, we investigated how p53 is regulated in precancerous lesions prior to mutations in the p53 gene. Analyzing esophageal cells in conditions of genotoxic stress that promotes development of esophageal adenocarcinoma, we find that p53 protein is adducted with reactive isolevuglandins (isoLGs), products of lipid peroxidation. Modification of p53 protein with isoLGs diminishes its acetylation and binding to the promoters of p53 target genes causing modulation of p53-dependent transcription...
January 31, 2023: Cell Reports
https://read.qxmd.com/read/36831211/the-runx-family-defines-trk-phenotype-and-aggressiveness-of-human-neuroblastoma-through-regulation-of-p53-and-mycn
#40
REVIEW
Kiyohiro Ando, Akira Nakagawara
The Runt-related transcription factor (RUNX) family, which is essential for the differentiation of cells of neural crest origin, also plays a potential role in neuroblastoma tumorigenesis. Consecutive studies in various tumor types have demonstrated that the RUNX family can play either pro-tumorigenic or anti-tumorigenic roles in a context-dependent manner, including in response to chemotherapeutic agents. However, in primary neuroblastomas, RUNX3 acts as a tumor-suppressor, whereas RUNX1 bifunctionally regulates cell proliferation according to the characterized genetic and epigenetic backgrounds, including MYCN oncogenesis...
February 8, 2023: Cells
keyword
keyword
8024
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.